FR1483M - Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique. - Google Patents

Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique.

Info

Publication number
FR1483M
FR1483M FR875633A FR875633A FR1483M FR 1483 M FR1483 M FR 1483M FR 875633 A FR875633 A FR 875633A FR 875633 A FR875633 A FR 875633A FR 1483 M FR1483 M FR 1483M
Authority
FR
France
Prior art keywords
hypnotic
sec
ethyl
methyl
barbituric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR875633A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A CASTAIGNE LAB
Original Assignee
A CASTAIGNE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A CASTAIGNE LAB filed Critical A CASTAIGNE LAB
Priority to FR875633A priority Critical patent/FR1483M/fr
Application granted granted Critical
Publication of FR1483M publication Critical patent/FR1483M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR875633A 1961-10-11 1961-10-11 Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique. Expired FR1483M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR875633A FR1483M (fr) 1961-10-11 1961-10-11 Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR875633A FR1483M (fr) 1961-10-11 1961-10-11 Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique.

Publications (1)

Publication Number Publication Date
FR1483M true FR1483M (fr) 1962-09-10

Family

ID=87764885

Family Applications (1)

Application Number Title Priority Date Filing Date
FR875633A Expired FR1483M (fr) 1961-10-11 1961-10-11 Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique.

Country Status (1)

Country Link
FR (1) FR1483M (fr)

Similar Documents

Publication Publication Date Title
FR2373M (fr) Nouveaux médicaments a base d'enzymes protéolytiques.
FR1704M (fr) Médicament anti-allergique et anti-histaminique a base de β-alanine.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR1483M (fr) Médicament hypnotique et sédatif a base d'acide n-méthyl-5-éthyl-5-sec.butyl barbiturique.
FR2288M (fr) Médicament analgésique et anti-émétique, a base de 1-phényl-3-(beta-diéthylamino-éthyl)-imidazolidones-(2).
FR2292M (fr) Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR2065M (fr) Médicament a action analgésique a base de phényl-alkylamine.
FR3458M (fr) Médicament a activité analgésique et sédative de la toux a base d'un nouvel alcaloide.
FR3026M (fr) Médicament narcotique a base d'ester n-propylique de l'acide 3-méthoxy-4-n-éthyloxy-n-éthylcarbaminométhoxyphénylacétique.
FR1974M (fr) Médicament a base d'un complexe de vitamine b12 et de tannin.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR2955M (fr) Médicament utilisable notamment comme analgésique et hypnotique a base de 4-alcoylamidophénylcarbonates d'haloalcoyle.
FR1411M (fr) Médicament a propriétés sédatives et d'épargne protidique a base de 4-hydroxy-butyrate de lysine.
FR2220M (fr) Médicament sédatif a base de dérivé de carbamate d'aryloxy-alcoyle.
FR2496M (fr) Médicament hypnotique et sédatif, a base de carbonate de 2,2,2-trichloroéthyle.
FR2201M (fr) Médicaments nouveaux a base de pyrimidinones.
FR100M (fr) Médicament cholérétique a base d'acide 1-cétocyclododécyl-2-acétique.
FR379M (fr) Médicament a propriétés hypnotiques et sédatives, a base d'(orthohydroxyphényl) 2-oxadiazole-1,3,4.
FR3141M (fr) Médicament a base d'un dérivé de pyrazolo [3.4-d] pyrimidine.
FR2392M (fr) Médicament hypnotique et sédatif a base de dérivés 3,3-disubstitués de la dicéto-2,6-pipérazine.
FR1268M (fr) Médicament antimitotique et antiviral.
FR2347M (fr) Médicament a base de sulfanilamides.
FR2141M (fr) Médicament a base de triméthobenzamide et de β-pyridyl-carbinol.
FR140M (fr) Nouveau médicament sédatif et hypnotique.